Clinical Trials Opportunities

jessicab

Recent Posts

A Study of GLWL-01 in Patients With Prader-Willi Syndrome

Study Purpose GLWL is conducting a Phase 2 clinical trial to to evaluate the efficacy, safety, and pharmacokinetics of GLWL-01 in treating hyperphagia in patients with PWS. Participants will be assigned to one of two treatment sequences (GLWL-01/Placebo or Placebo/GLWL-01), with each sequence consisting of two treatment periods separated by a washout period.

Survey Measuring the Impact of PWS on Caregivers

OVERVIEW

Characterizing pain in individuals with PWS

Researchers at Vrije University in Amsterdam are conducting a study to better understand how individuals with PWS perceive and feel pain. For more information, please see the recruitment flyer for the Pain Questionnaire study and contact postdocteam.fgb@vu.nl.

Toward a better understanding of what it is like to care for and parent a child with PWS

In this study, adults will be interviewed 3 times over a 6 month period will be asked questions about personal and family health, family history and routines and what everyday living is like caring for a child with PWS.

Improving Social Skills in PWS with an online Social Skills Group

Researchers at Vanderbilt Kennedy Center in Nashville, Tennessee are conducting a study to improve and learn new social skills in PWS with an online social skills group. The project uses your home computer/laptop with webcam to participate in a group of PWS friends aged 16-26 years. The group will meet 3X/week for 10 weeks. For more information, please contact: Hailee Hunt-Hawkins hailee.m.hunt@vanderbilt.edu at 615-343-0915 Elizabeth Roof elizabeth.roof@vanderbilt.edu at 615-343-3330

Phase 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome

NO LONGER RECRUITING

Phase 3 Trial of ZGN-440 (Beloranib) in Overweight or Obese Subjects With Prader-Willi Syndrome (bestPWS)

UPDATE: This study was terminated. Zafgen has decided to cease development of Beloranib due to high risk of thrombotic events. See the letter from Zafgen to the PWS community.

Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome

The purpose of this study is to determine the presence of central adrenal insufficiency in children with Prader Willi Syndrome using low dose (1 mcg) ACTH stimulation test compared to results of overnight metyrapone test. The study is being conducted at Nationwide Children's Hospital in Columbus, Ohio. For more information, visit clinicaltrials.gov here or contact the study coordinator.

Generating PWS stem cells from cord blood samples

NO LONGER RECRUITING

Oxytocin Trial in Prader-Willi Syndrome

Update: This Phase I study has been completed - we look forward to publication of the results, and the next steps of oxytocin development.

Tools for PWS Awareness

Volunteer Your Time

No matter how big or how small, every effort helps us!

VOLUNTEER